Daily Upgrades and Downgrades: (DGX)

Quest Diagnostics (DGX) is currently being analyzed by the brokerage firm RBC Capital Mkts. They have just changed their rating from Outperform to Sector Perform. This indicates that the company may not be doing as well as investors were expecting. Look for potential selling pressure or a downside move in the share price. The target price is currently set at $61 per share by the brokerage firm. Shares of DGX fell by 0.43% or $-0.25/share to $58.11. In the past year, the shares have traded as low as $43.38 and as high as $61.21. On average, 1587910 shares of DGX exchange hands on a given day and today's volume is recorded at 2243271.